Apoptin-associating protein
CA 2397571 A1 · Owner: Danen-Van Oorschot, Astrid Adriana Anna Maria · Inventors: Danen-Van Oorschot, Astrid Adriana Anna Maria; Weiss, Bertram; Noteborn, Mathieu Hubertus Maria
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the field of apoptosis. The invention provides novel therapeutic possibilities, for example novel combinatorial therapies or novel therapeutic compounds that can work alone sequentially to, or jointly with , Apoptin especially in those cases wherein p53 is (partly) non-functional.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 17, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 17, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 17, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.